The New Energy Crisis No One Saw Coming
Free investor report reveals how the electric car initiative is putting the U.S. in peril...and shows how to potentially capitalize on this crisis with a junior mining company.
See how this new energy crisis could create a boom

Jonathan Lord Biography and Net Worth

Director of BIOLASE

A nationally recognized leader in innovations in health care, Jonathan "Jack" Lord, M.D, is actively engaged in driving change in healthcare through new technologies and therapies. Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. He later served as a senior executive in a variety of healthcare organizations - the Anne Arundel Medical Center, SunHealth and as the chief operating officer of the American Hospital Association. Lord was the former chief innovation officer and senior vice president of Humana - during his time at Humana, he created Humana's Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Recently he served as the Chief Innovation Officer and Chief Operating Officer of the Miller School of Medicine at the University of Miami; he is a double alumnus of the University of Miami.

Dr. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention's Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine

Dr. Lord focuses on the commercialization of disruptive innovations that change people lives; including companies that have done that - Health Dialog, Humana, Therasense, Stericycle, Mako Surgical and Dexcom. Today he serves as the Chair of the Board of Directors of Dexcom (DXCM), is a Director for BIOLASE (BIOL), Digital Reasoning, Par8o, Creative Vascular, Hubble Telemedical, and Vigilant Biosciences. He also serves on advisory board roles for Qualcomm Life (mobile health) and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School.

What is Jonathan T. Lord's net worth?

The estimated net worth of Jonathan T. Lord is at least $450,173.10 as of November 16th, 2018. Dr. Lord owns 577,145 shares of BIOLASE stock worth more than $450,173 as of December 6th. This net worth estimate does not reflect any other assets that Dr. Lord may own. Learn More about Jonathan T. Lord's net worth.

How do I contact Jonathan T. Lord?

The corporate mailing address for Dr. Lord and other BIOLASE executives is 27042 Towne Center Drive Suite 270, Lake Forest CA, 92610. BIOLASE can also be reached via phone at (949) 361-1200 and via email at [email protected] Learn More on Jonathan T. Lord's contact information.

Has Jonathan T. Lord been buying or selling shares of BIOLASE?

Jonathan T. Lord has not been actively trading shares of BIOLASE over the course of the past ninety days. Most recently, Jonathan T. Md Lord sold 11,038 shares of the business's stock in a transaction on Wednesday, December 15th. The shares were sold at an average price of $0.38, for a transaction totalling $4,194.44. Learn More on Jonathan T. Lord's trading history.

Who are BIOLASE's active insiders?

BIOLASE's insider roster includes John Beaver (CEO), and Jonathan Lord (Director). Learn More on BIOLASE's active insiders.

Are insiders buying or selling shares of BIOLASE?

In the last twelve months, insiders at the medical technology company sold shares 1 times. They sold a total of 11,038 shares worth more than $4,194.44. The most recent insider tranaction occured on December, 15th when Director Jonathan T Md Lord sold 11,038 shares worth more than $4,194.44. Insiders at BIOLASE own 2.1 % of the company. Learn More about insider trades at BIOLASE.

Information on this page was last updated on 12/15/2021.

Jonathan T. Lord Insider Trading History at BIOLASE

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2021Sell11,038$0.38$4,194.44View SEC Filing Icon  
11/16/2018Buy10,000$1.36$13,600.00577,145View SEC Filing Icon  
8/14/2018Buy100,000$1.31$131,000.00536,547View SEC Filing Icon  
8/10/2018Buy69,402$1.25$86,752.50536,547View SEC Filing Icon  
11/3/2014Buy101,163$2.39$241,779.57View SEC Filing Icon  
See Full Table

Jonathan T. Lord Buying and Selling Activity at BIOLASE

This chart shows Jonathan T Md Lord's buying and selling at BIOLASE by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BIOLASE Company Overview

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Read More

Today's Range

Now: $0.78
Low: $0.78
High: $0.87

50 Day Range

MA: $1.80
Low: $0.82
High: $2.66

2 Week Range

Now: $0.78
Low: $0.76
High: $13.83


241,277 shs

Average Volume

67,235 shs

Market Capitalization

$5.57 million

P/E Ratio


Dividend Yield



Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
See This Special Report to Get the Full Story